The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4, 4-bis (3-methyl-2-thienyl)-3-butenyl]-3- …

KE Andersen, C Braestrup, FC Groenwald…

Index: Andersen, Knud Erik; Braestrup, Claus; Groenwald, Frederik C.; Joergensen, Anker S.; Nielsen, Erik B.; et al. Journal of Medicinal Chemistry, 1993 , vol. 36, # 12 p. 1716 - 1725

Full Text: HTML

Citation Number: 121

Abstract

Introduction y-Aminobutyric acid (GABA) is recognized as the principal inhibitory neurotransmitter in the mammalian central nervous system (CNS). lv2 It has been estimated that approximately 40% of synapses in the CNS are GABA'ergic. 3 Attenuation of GABA'ergic neurotransmission has been postulated as being involved in the pathophysiology of several CNS disorders in humans, for example anxiety, pain, and epilepsy.-As a result, much ...

Related Articles:

Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I)

[Zheng, Jianbin; Wen, Ren; Luo, Xiaomin; Lin, Guoqiang; Zhang, Jiange; Xu, Linfeng; Guo, Lihe; Jiang, Hualiang Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 1 p. 225 - 227]

Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I)

[Zheng, Jianbin; Wen, Ren; Luo, Xiaomin; Lin, Guoqiang; Zhang, Jiange; Xu, Linfeng; Guo, Lihe; Jiang, Hualiang Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 1 p. 225 - 227]

More Articles...